Pancreatic Cancer New Protocol: Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer Ulas D. Bayraktar, MD 2023-06-07
Pancreatic Cancer New Indication: Sotorasib in kRAS G12C Mutant Pancreatic Cancer Ulas D. Bayraktar, MD 2023-03-15
